Search results
Results from the WOW.Com Content Network
Cancer Immunology, Immunotherapy is a monthly peer-reviewed medical journal published by Springer Science+Business Media. According to the Journal Citation Reports, the journal has a 2020 impact factor of 6.968. [1]
Cancer Immunology Research is a monthly peer-reviewed medical journal published by the American Association for Cancer Research. It covers research and clinical trials related to the study of cancer immunology. The editors-in-chief are Robert D. Schreiber and Philip Greenberg. [1] The journal was established in 2013. [1]
Anticancer Research was established in 1981 by John G. Delinassios. According to the Journal Citation Reports, the journal had a 2020 impact factor of 2.480 and 25,656 total cites. The 2020 rejection rate was 68%. According to Scimago, the journal belongs to the second quartile (Q2) in the "Medicine" category.
Cancer Discovery has become a premier journal in the field of cancer research, with a 2020 impact factor of 39.397 that is the highest among the AACR journals. [6] [7] Research published in the journal includes identification of actionable genomic alterations in cancer, mechanisms of therapy resistance, clinical trials on targeted therapy, and ...
Cancer immunotherapy (immuno-oncotherapy) is the stimulation of the immune system to treat cancer, improving the immune system's natural ability to fight the disease. [1] It is an application of the fundamental research of cancer immunology ( immuno-oncology ) and a growing subspecialty of oncology .
Tumor-associated immune cells in the tumor microenvironment (TME) of breast cancer models. Cancer immunology (immuno-oncology) is an interdisciplinary branch of biology and a sub-discipline of immunology that is concerned with understanding the role of the immune system in the progression and development of cancer; the most well known application is cancer immunotherapy, which utilises the ...
The Cancer Research Institute (CRI) is a US non-profit organization funding cancer research and based in New York City. They were founded in 1953 to develop immunologically-based treatments for cancer, and despite their name are a funding body for research rather than a research institute themselves, working with other institutes and organizations.
A major application of cellular adoptive therapy is cancer treatment, as the immune system plays a vital role in the development and growth of cancer. [1] The primary types of cellular adoptive immunotherapies are T cell therapies. Other therapies include CAR-T therapy, CAR-NK therapy, macrophage-based immunotherapy and dendritic cell therapy.